España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
TetraLogic Pharma
TLOG
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
TetraLogic Pharma (TLOG) Forecast
News
Earnings
TetraLogic Pharma (TLOG) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for TetraLogic Pharma (OTC:TLOG) Stock
TetraLogic Pharma Stock (OTC: TLOG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Thursday, August 08, 2019
Stocks That Set New 52-Week Highs Thursday
Lisa Levin
Wednesday, November 02, 2016
TetraLogic Agrees To Sell Assets To Medivir A...
Benzinga
TetraLogic Pharmaceuticals Halted; Pending Ne...
Benzinga
TetraLogic Pharma Shares Halted News Pending
Benzinga
Tuesday, June 21, 2016
Worst Performing Industries For June 21, 2016
Benzinga
Thursday, April 07, 2016
Tetralogic Pharma Says CFO/Treasurer Pete Mey...
Benzinga
Thursday, January 07, 2016
Here's Why Tetralogic Pharmaceuticals Is Down 70%
Benzinga
Wednesday, January 06, 2016
TetraLogic Pharma Shares Continue To Fall Aft...
Benzinga
UPDATE: TetraLogic Pharmaceuticals birinapant...
Benzinga
TetraLogic Pharmaceuticals Says Birinapant Shows No Activity in Randomized Phase 2 MDS Study; SHAPE Shows Clinical Benefit in Randomized Phase 2 CTCL Study
Benzinga
Tetralogic Shares Halted News Pending
Benzinga
Thursday, December 31, 2015
Roth Capital's New Buy Rating On TetraLogic: 'SMAC'ing Cancer Around'
Benzinga
Wednesday, December 30, 2015
UPDATE: Roth Capital Says TetraLogic's Birina...
Benzinga
Roth Capital Initiates Coverage on TetraLogic Pharmaceutical at Buy, Announces $5.00 PT
Benzinga
Tuesday, December 01, 2015
Tetralogic Pharma Shares Sell Off Below $2, D...
Benzinga
Tuesday, August 25, 2015
Tetralogic Pharma Announces Lincoln Park Capi...
Benzinga
Monday, August 24, 2015
Morning Market Losers
Benzinga
Wednesday, August 05, 2015
TetraLogic Pharma Reports Q2 Loss $0.51 Vs Es...
Benzinga
Monday, July 20, 2015
TetraLogic Gives Update on Hepatitis B Clinical Program
Benzinga
Monday, July 06, 2015
Tetralogic Pharmaceuticals Director Schmitt B...
Benzinga
Wednesday, July 01, 2015
Mid-Day Market Update: Chubb Surges Following Announcement of Acquisition by Ace; Ballard Power Shares Decline
Benzinga
Mid-Morning Market Update: Markets Open Higher; Constellation Brands Q1 Profit Tops Views
Benzinga
Morning Market Gainers
Benzinga
Tuesday, June 30, 2015
Tetralogic, Freeport-McMoRan, Melco Crown Lead Tuesday's After-Hours Movers
Benzinga
TetraLogic Announces Update on MDS Clinical Program
Benzinga
Wednesday, May 06, 2015
PREVIEW: TetraLogic Pharmaceuticals to Resume...
Benzinga
TetraLogic Announces Termination of Public Of...
Benzinga
TetraLogic Shares Halted News Pending
Benzinga
Shares of TetraLogic Resume Trade Following S...
Benzinga
TetraLogic Shares Halted on Second Circuit Br...
Benzinga
Shares of TetraLogic Resume Trade Following C...
Benzinga
Shares of TetraLogic Halted on Circuit Breake...
Benzinga
TetraLogic Pharma Shares Resume Trade, Plunge...
Benzinga
Shares of TetraLogic to Resume Trade at 10:45...
Benzinga
UPDATE: TetraLogic Reports Temporary Halt of Chronic Hep B Trial
Benzinga
TetraLogic Reports Temporary Halt of Chronic ...
Benzinga
Shares of TetraLogic Halted News Pending
Benzinga
Friday, May 01, 2015
Morning Market Losers
Benzinga
Tetralogic Prices 6.25M Shares at $4/Share
Benzinga
Benzinga's Top #PreMarket Losers
Benzinga
Monday, April 20, 2015
Morning Market Gainers
Benzinga
Tetralogic Announces Co., Merck Will Collabor...
Benzinga
Thursday, February 26, 2015
TetraLogic Pharma Reports Q4 EPS -$0.53 Vs Es...
Benzinga
Friday, January 09, 2015
Tetralogic Pharmaceuticals CEO Buchi Buys 5,0...
Benzinga
Friday, January 02, 2015
Tetralogic Pharma Files $150M Mixed Securitie...
Benzinga
Thursday, December 18, 2014
US Stock Futures Signal Higher Start On Wall Street
Benzinga
TetraLogic Reports Initiation of Randomized Phase 2 Trial of SHAPE for Cutaneous T-Cell Lymphoma
Benzinga
Tuesday, December 16, 2014
TetraLogic Provides Update on Ovarian Cancer Study
Benzinga
Thursday, November 13, 2014
Tetralogic Pharmaceuticals CFO Meyers Buys 5,...
Benzinga
Show More